# Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy

> **NCT02679586** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 25 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Diffusion weighted MRI

## Key facts

- **NCT ID:** NCT02679586
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2013-03
- **Final completion:** —
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02679586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02679586, "Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02679586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*